The Procter & Gamble Company (PG) 10-Q 20 Apr 20 2020 Q3 Quarterly report Financial data

DOCUMENT AND ENTITY INFORMATION

DOCUMENT AND ENTITY INFORMATION	9 Months Ended
	Mar. 31, 2020shares
Entity Information [Line Items]
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	2,475,642,613
Entity Emerging Growth Company	false
Entity Central Index Key	0000080424
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2020
Amendment Flag	false
Entity Incorporation, State or Country Code	OH
Entity File Number	1-434
Entity Tax Identification Number	31-0411980
Entity Address, Address Line One	One Procter & Gamble Plaza
Entity Address, City or Town	Cincinnati
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	45202
City Area Code	513
Document Transition Report	false
Document Quarterly Report	true
Document Type	10-Q
Trading Symbol	PG
Local Phone Number	983-1100
Entity Current Reporting Status	Yes
Document Period End Date	Mar. 31, 2020
Entity Registrant Name	PROCTER & GAMBLE CO
Entity Small Business	false
Entity Interactive Data Current	Yes
Entity Shell Company	false
1.875% due 2038 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.875% Notes due 2038
Trading Symbol	PG38
5.250% GBP due January 2033 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	5.250% GBP notes due January 2033
Trading Symbol	PG33
6.250% GBP due January 2030 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	6.250% GBP notes due January 2030
Trading Symbol	PG30
1.800% due 2029 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.800% Notes due 2029
Trading Symbol	PG29A
1.250% due 2029 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.250% Notes due 2029
Trading Symbol	PG29B
1.200% due 2028 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.200% Notes due 2028
Trading Symbol	PG28
4.875% EUR due May 2027 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	4.875% EUR notes due May 2027
Trading Symbol	PG27A
1.375% due 2025 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.375% Notes due 2025
Trading Symbol	PG25
0.625% due 2024 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	0.625% Notes due 2024
Trading Symbol	PG24B
0.500% due 2024 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	0.500% Notes due 2024
Trading Symbol	PG24A
1.125% due 2023 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	1.125% Notes due 2023
Trading Symbol	PG23A
2.000% due 2022 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	2.000% Notes due 2022
Trading Symbol	PG22B
2.000% due 2021 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	2.000% Notes due 2021
Trading Symbol	PG21
0.275% due 2020 [Domain] [Domain]
Entity Information [Line Items]
Title of 12(b) Security	0.275% Notes due 2020
Trading Symbol	PG20
Common Stock [Member]
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, without Par Value
Trading Symbol	PG
4.125% EUR due December 2020 [Domain]
Entity Information [Line Items]
Title of 12(b) Security	4.125% EUR notes due December 2020
Trading Symbol	PG20A
NEW YORK STOCK EXCHANGE, INC. [Member]
Entity Information [Line Items]
Security Exchange Name	NYSE
NEW YORK STOCK EXCHANGE, INC. [Member] | Common Stock [Member]
Entity Information [Line Items]
Security Exchange Name	NYSE

CONSOLIDATED STATEMENTS OF EARN

CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Net Sales		$ 17,214	$ 16,462	$ 53,252	$ 50,590
Cost of Products Sold		8,716	8,427	26,308	25,830
Selling, General and Administrative Expense		5,045	4,806	14,719	14,081
Operating Income		3,453	3,229	12,225	10,679
Interest Expense		(100)	(131)	(308)	(398)
Interest Income		39	52	133	168
Other Non-operating Income/(Loss), Net		106	128	323	685
Earnings/(Loss) from Continuing Operations Before Income Taxes		3,498	3,278	12,373	11,134
Income Taxes on Continuing Operations		541	502	2,056	1,931
Net Earnings		2,957	2,776	10,317	9,203
Net Income (Loss) Attributable to Noncontrolling Interest		$ 40	$ 31	$ 90	$ 65
Basic Net Earnings Per Common Share
Basic Net Earnings Per Common Share	[1],[2]	$ 1.15	$ 1.07	$ 4.03	$ 3.58
Diluted Net Earnings Per Common Share
Diluted Net Earnings Per Common Share	[1],[2]	$ 1.12	$ 1.04	$ 3.89	$ 3.48
Diluted Weighted Average Common Shares Outstanding		2,613.3	2,637.7	2,630.3	2,624.3
Noncontrolling Interest [Member]
Net Income (Loss) Attributable to Noncontrolling Interest		$ 40	$ 31	$ 90	$ 65
Retained Earnings [Member]
Net Earnings Attributable to Procter & Gamble		$ 2,917	$ 2,745	$ 10,227	$ 9,138
[1]	Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[2]	Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

CONDOLIDATED STATEMENTS OF COMP

CONDOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Net Earnings	$ 2,957	$ 2,776	$ 10,317	$ 9,203
Foreign Currency Translation	(1,164)	73	(1,312)	(314)
Unrealized Gains/(Losses) on Investment Securities	(6)	54	(12)	107
Unrealized Gains/(Losses) on Defined Benefit Retirement Plans	185	64	327	314
Total Other Comprehensive Income (Loss), Net of Tax	(985)	191	(997)	107
Total Comprehensive Income/(Loss)	1,972	2,967	9,320	9,310
Less: Total Comprehensive Income Attributable to Noncontrolling Interest	29	34	73	65
Total Comprehensive Income/(Loss) Attributable to Procter & Gamble	$ 1,943	$ 2,933	$ 9,247	$ 9,245

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions	Mar. 31, 2020	Jun. 30, 2019
Current Assets
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 15,393	$ 4,239
Available-for-Sale Investment Securities	0	6,048
Accounts Receivable	4,640	4,951
Inventories
Materials and Supplies	1,325	1,289
Work in Process	635	612
Finished Goods	3,370	3,116
Total Inventories	5,330	5,017
Prepaid Expenses and Other Current Assets	1,777	2,218
Total Current Assets	27,140	22,473
Property, Plant and Equipment, Net	20,459	21,271
Goodwill	39,617	40,273
Trademarks and Other Intangible Assets, Net	23,834	24,215
Other Noncurrent Assets	7,510	6,863
Total Assets	118,560	115,095
Current Liabilities
Accounts Payable	10,464	11,260
Accrued and Other Liabilities	9,731	9,054
Debt Due Within One Year	12,701	9,697
Total Current Liabilities	32,896	30,011
Long-Term Debt	23,310	20,395
Deferred Income Tax Liabilities, Net	6,309	6,899
Other Noncurrent Liabilities	10,104	10,211
Total Liabilities	72,619	67,516
Shareholders' Equity
Preferred Stock	$ 900	$ 928
Common Stock, Shares, Issued	4,009.2	4,009.2
Common Stock, Value, Issued	$ 4,009	$ 4,009
Additional Paid in Capital	63,976	63,827
Reserve For ESOP Debt Retirement	(1,080)	(1,146)
Accumulated Other Comprehensive Income/(Loss)	(15,916)	(14,936)
Treasury Stock	(105,823)	(100,406)
Retained Earnings	99,474	94,918
Noncontrolling Interest	401	385
Total Shareholders' Equity	45,941	47,579
Total Liabilities and Shareholders' Equity	$ 118,560	$ 115,095

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Millions	Total	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Reserve for ESOP Debt Retirement [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Cash Paid	$ 2.1516
Common Stock, Shares, Outstanding, Beginning Balance at Jun. 30, 2018		2,498,093
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jun. 30, 2018	$ 52,883	$ 4,009	$ 967	$ 63,846	$ (1,204)	$ (14,749)	$ (99,217)	$ 98,641	$ 590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss) Attributable to Parent								9,138
Net Income (Loss) Attributable to Noncontrolling Interest	65								65
Cumulative Effect on Retained Earnings, Net of Tax	(553)					(326)		(200)	(27)
Net Earnings	9,203
Other Comprehensive Income (Loss), Net of Tax	107					107			0
Dividends, Common Stock	(5,380)							(5,380)
Dividends, Preferred Stock	(195)							(195)
Stock Repurchased During Period, Shares		(37,282)
Stock Repurchased During Period, Value	(3,253)						(3,253)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		43,586
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	2,847			(110)			2,957
Stock Issued During Period, Shares, Conversion of Convertible Securities		3,933
Stock Issued During Period, Value, Conversion of Convertible Securities	0		(34)	5			29
ESOP Debt Impacts	158				59			99
Noncontrolling Interest, Period Increase (Decrease)	(265)			(117)					(148)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2019		2,508,330
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2019	$ 55,552	$ 4,009	933	63,624	(1,145)	(14,968)	(99,484)	102,103	480
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Cash Paid	$ 0.7172
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2018		2,501,580
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018	$ 54,443	$ 4,009	946	63,679	(1,178)	(15,156)	(99,480)	101,170	453
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss) Attributable to Parent								2,745
Net Income (Loss) Attributable to Noncontrolling Interest	31								31
Net Earnings	2,776
Other Comprehensive Income (Loss), Net of Tax	191					188			3
Dividends, Common Stock	(1,799)							(1,799)
Dividends, Preferred Stock	(64)							(64)
Stock Repurchased During Period, Shares		(12,945)
Stock Repurchased During Period, Value	(1,250)						(1,250)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		18,197
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	1,178			(57)			1,235
Stock Issued During Period, Shares, Conversion of Convertible Securities		1,498
Stock Issued During Period, Value, Conversion of Convertible Securities	0		(13)	(2)			11
ESOP Debt Impacts	84				33			51
Noncontrolling Interest, Period Increase (Decrease)	(7)			0					(7)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2019		2,508,330
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2019	$ 55,552	$ 4,009	933	63,624	(1,145)	(14,968)	(99,484)	102,103	480
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Cash Paid	$ 2.2377
Common Stock, Shares, Outstanding, Beginning Balance at Jun. 30, 2019		2,504,751
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jun. 30, 2019	$ 47,579	$ 4,009	928	63,827	(1,146)	(14,936)	(100,406)	94,918	385
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss) Attributable to Parent								10,227
Net Income (Loss) Attributable to Noncontrolling Interest	90								90
Net Earnings	10,317
Other Comprehensive Income (Loss), Net of Tax	(997)					(980)			(17)
Dividends, Common Stock	(5,587)							(5,587)
Dividends, Preferred Stock	(193)							(193)
Stock Repurchased During Period, Shares		(61,346)
Stock Repurchased During Period, Value	(7,405)						(7,405)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		28,965
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	2,109			145			1,964
Stock Issued During Period, Shares, Conversion of Convertible Securities		3,273
Stock Issued During Period, Value, Conversion of Convertible Securities	0		(28)	4			24
ESOP Debt Impacts	175				66			109
Noncontrolling Interest, Period Increase (Decrease)	(57)			0					(57)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2020		2,475,643
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2020	$ 45,941	$ 4,009	900	63,976	(1,080)	(15,916)	(105,823)	99,474	401
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Cash Paid	$ 0.7459
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019		2,469,453
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019	$ 45,908	$ 4,009	911	64,019	(1,112)	(14,942)	(105,761)	98,414	370
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss) Attributable to Parent								2,917
Net Income (Loss) Attributable to Noncontrolling Interest	40								40
Net Earnings	2,957
Other Comprehensive Income (Loss), Net of Tax	(985)					(974)			(11)
Dividends, Common Stock	(1,850)							(1,850)
Dividends, Preferred Stock	(64)							(64)
Stock Repurchased During Period, Shares		(7,313)
Stock Repurchased During Period, Value	(901)						(901)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		12,234
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	785			(44)			829
Stock Issued During Period, Shares, Conversion of Convertible Securities		1,269
Stock Issued During Period, Value, Conversion of Convertible Securities	0		(11)	1			10
ESOP Debt Impacts	89				32			57
Noncontrolling Interest, Period Increase (Decrease)	2			0					2
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2020		2,475,643
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2020	$ 45,941	$ 4,009	$ 900	$ 63,976	$ (1,080)	$ (15,916)	$ (105,823)	$ 99,474	$ 401

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Cash Flows [Abstract]
Cash, Cash Equivalent and Restricted Cash Beginning of Period	$ 4,239	$ 2,569
Operating Activities
Net Earnings	10,317	9,203
Depreciation and Amortization	2,199	2,004
Share-based Compensation Expense	325	299
Deferred Income Taxes	(588)	(24)
Gain (Loss) on Disposition of Assets	11	(370)
Changes In:
Accounts Receivable	135	(549)
Inventories	(533)	(601)
Accounts Payable, Accrued and Other Liabilities	738	1,441
Other Operating Assets and Liabilities	(58)	(537)
Other Noncash Expense	51	225
Total Operating Activities	12,597	11,091
Investing Activities
Capital Expenditures	(2,415)	(2,533)
Proceeds from Asset Sales	28	22
Acquisitions, Net of Cash Acquired	(58)	(3,943)
Purchases of Short-term Investments	0	(159)
Proceeds from Sales of Short-term Investments	6,151	2,535
Change in Other Investments	(2)	(59)
Total Investing Activites	3,704	(4,137)
Financing Activities
Dividends to Shareholders	(5,761)	(5,561)
Change in Short-term Debt	3,020	(1,832)
Proceeds from (Repayments of) Other Long-term Debt	4,951	2,368
Repayments of Long-term Debt	(1,534)	(1,002)
Treasury Stock Purchases	(7,405)	(3,253)
Impact of Stock Options and Other	1,761	2,590
Total Financing Activities	(4,968)	(6,690)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(179)	(95)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	11,154	169
Cash, Cash Equivalents and Restricted Cash, End of Period	$ 15,393	$ 2,738

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Basis of PresentationThese statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019. In the opinion of management, the accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries (the "Company," "Procter & Gamble," "P&G," "we" or "our") contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.

NEW ACCOUNTING PRONOUNCEMENTS A

NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES	9 Months Ended
	Mar. 31, 2020
Accounting Changes and Error Corrections [Abstract]
Accounting Changes and Error Corrections [Text Block]	New Accounting Pronouncements and Policies On July 1, 2019, we adopted ASU 2016-02, "Leases (Topic 842)." The new accounting standard requires the recognition of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. We elected the optional transition method and adopted the new guidance on a modified retrospective basis with no restatement of prior period amounts. As allowed under the new accounting standard, we elected to apply practical expedients to carry forward the original lease determinations, lease classifications and accounting of initial direct costs for all asset classes at the time of adoption. The adoption did not have a material impact on our financial statements, resulting in an increase of approximately 1% to each of our total assets and total liabilities on our balance sheet as of July 1, 2019. See Note 10 for further information. In January 2017, the FASB issued ASU 2017-04, "Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The standard simplifies the accounting for goodwill impairment by requiring a goodwill impairment to be measured using a single step impairment model, whereby the impairment equals the difference between the carrying amount and the estimated fair value of the specified reporting units in their entirety. This eliminates the second step of the current impairment model that requires companies to first estimate the fair value of all assets in a reporting unit and measure impairments based on those estimated fair values and a residual measurement approach. It also specifies that any loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. We will adopt the standard effective July 1, 2020. The impact of the new standard will be dependent on the specific facts and circumstances of future individual impairments, if any. In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The amendments provide optional guidance for a limited time to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. We are currently evaluating our contracts and the optional expedients provided by the new standard. No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.

SEGMENT INFORMATION

SEGMENT INFORMATION	9 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	Segment Information Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of: • Beauty : Hair Care (Conditioner, Shampoo, Styling Aids, Treatments); Skin and Personal Care (Antiperspirant and Deodorant, Personal Cleansing, Skin Care); • Grooming : Shave Care (Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care); Appliances • Health Care : Oral Care (Toothbrushes, Toothpaste, Other Oral Care); Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Pain Relief, Other Personal Health Care); • Fabric & Home Care : Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&G Professional, Surface Care); and • Baby, Feminine & Family Care : Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence, Feminine Care); Family Care (Paper Towels, Tissues, Toilet Paper). Our operating segments are comprised of similar product categories. Operating segments that individually accounted for 5% or more of consolidated net sales are as follows: % of Net sales by operating segment (1) Three Months Ended March 31 Nine Months Ended March 31 2020 2019 2020 2019 Fabric Care 23% 22% 23% 23% Baby Care 11% 12% 11% 12% Home Care 11% 11% 10% 10% Skin and Personal Care 9% 10% 10% 10% Hair Care 9% 9% 9% 9% Family Care 9% 8% 9% 9% Oral Care 8% 8% 8% 8% Shave Care 7% 8% 7% 8% Feminine Care 7% 6% 6% 6% Personal Health Care 5% 5% 5% 4% Other 1% 1% 2% 1% Total 100% 100% 100% 100% (1) % of Net sales by operating segment excludes sales held in Corporate. Following is a summary of reportable segment results: Three Months Ended March 31 Nine Months Ended March 31 Net Sales Earnings/(Loss) Before Income Taxes Net Earnings Net Sales Earnings/(Loss) Before Income Taxes Net Earnings Beauty 2020 $ 3,033 $ 553 $ 436 $ 10,183 $ 2,717 $ 2,168 2019 3,061 675 551 9,707 2,586 2,082 Grooming 2020 1,380 305 254 4,559 1,225 1,018 2019 1,424 329 344 4,603 1,194 1,062 Health Care 2020 2,262 523 408 7,013 1,795 1,380 2019 2,115 462 358 6,180 1,571 1,210 Fabric & Home Care 2020 5,826 1,271 957 17,445 3,887 2,960 2019 5,382 1,114 847 16,427 3,392 2,584 Baby, Feminine & Family Care 2020 4,597 1,130 859 13,746 3,340 2,552 2019 4,357 861 653 13,305 2,693 2,052 Corporate 2020 116 (284) 43 306 (591) 239 2019 123 (163) 23 368 (302) 213 Total Company 2020 $ 17,214 $ 3,498 $ 2,957 $ 53,252 $ 12,373 $ 10,317 2019 16,462 3,278 2,776 50,590 11,134 9,203

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	9 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	Goodwill and Other Intangible Assets Goodwill is allocated by reportable segment as follows: Beauty Grooming Health Care Fabric & Home Care Baby, Feminine & Family Care Total Company Goodwill at June 30, 2019 $ 12,985 $ 12,881 $ 7,972 $ 1,855 $ 4,580 $ 40,273 Acquisitions and divestitures (1) — (46) — 5 (42) Translation and other (189) (143) (201) (23) (58) (614) Goodwill at March 31, 2020 $ 12,795 $ 12,738 $ 7,725 $ 1,832 $ 4,527 $ 39,617 Goodwill from current year acquisitions and divestitures primarily reflects opening balance sheet adjustments from the prior year acquisition of the over-the-counter (OTC) healthcare business of Merck KGaA (Merck OTC) in the Health Care reportable segment (see Note 12), along with a minor Baby Care acquisition in the current year and adjustments from a prior year Beauty acquisition. Identifiable intangible assets at March 31, 2020 were comprised of: Gross Carrying Amount Accumulated Amortization Intangible assets with determinable lives $ 8,458 $ (5,628) Intangible assets with indefinite lives 21,004 — Total identifiable intangible assets $ 29,462 $ (5,628) Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives consist of brands. The amortization expense of determinable lived intangible assets for the three months ended March 31, 2020 and 2019 was $87 and $98, respectively. For the nine months ended March 31, 2020 and 2019, the amortization expense was $274 and $252, respectively. Goodwill and indefinite lived intangible assets are not amortized but are tested annually for impairment. The test to evaluate goodwill for impairment is a two-step process. In the first step, we compare the fair value of the reporting unit to its carrying value. If the fair value of the reporting unit is less than the carrying value, we perform a second step (the step two testing) to determine the implied fair value of the reporting unit's goodwill. The step two testing of the impairment analysis requires a valuation of a reporting unit's tangible and intangible assets and liabilities in a manner similar to the allocation of purchase price in a business combination. If the resulting implied fair value of the reporting unit's goodwill is less than its carrying value, that difference represents an impairment. The business unit valuations used to test goodwill and intangible assets for impairment are dependent on a number of significant estimates and assumptions, including macroeconomic conditions, overall category growth rates, competitive activities, cost containment, margin expansion and Company business plans. We believe these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount and tax rates or future cash flow projections, could result in significantly different estimates of the fair values. Our annual impairment testing for goodwill and indefinite lived intangible assets occurs during the three months ended December 31. Most of our goodwill reporting units are comprised of a combination of legacy and acquired businesses and as a result have fair value cushions that, at a minimum, exceed two times their underlying carrying values. Certain of our goodwill reporting units, in particular Shave Care and Appliances, are comprised entirely of acquired businesses and as a result, have fair value cushions that are not as high. The Appliances reporting unit has a fair value that significantly exceeds the underlying carrying value. As previously disclosed, the carrying value of the Shave Care reporting unit and the related Gillette indefinite-lived intangible asset were impaired during the quarter ended June 30, 2019. The underlying reductions in fair values were due in large part to significant currency devaluations in a number of countries relative to the U.S. dollar, a deceleration of category growth caused by changing grooming habits, primarily in the developed markets, and an increased competitive market environment in the U.S. and certain other markets. As a result of the June 30, 2019 impairment determined by the step two testing, the Shave Care fair value exceeded the carrying value by approximately 20% as of June 30, 2019. Because the impairment testing for intangible assets is a one-step process, the Gillette indefinite-lived intangible asset fair value approximated its carrying value at that date. During our annual impairment testing during the quarter ended December 31, 2019, we reduced the discount rate used in the valuation based on developments in the macroeconomic environment. As a result of this change and updates to other underlying cash flow projections, the Shave Care fair value exceeded the carrying value by more than 20% and the Gillette indefinite-lived intangible asset fair value exceeded the carrying value by approximately 5%. The Gillette indefinite-lived intangible asset is most susceptible to future impairment risk. The most significant assumptions utilized in the determination of the estimated fair values of Shave Care reporting unit and the Gillette indefinite-lived intangible asset are the net sales and earnings growth rates (including residual growth rates) and discount rate. The residual growth rate represents the expected rate at which the reporting unit and Gillette brand are expected to grow beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the reporting unit and brand operating plans and approximates expected long term category market growth rates. The residual growth rate is dependent on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment. The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S. While management can and has implemented strategies to address these events, changes in operating plans or adverse changes in the business or in the macroeconomic environment in the future could reduce the underlying cash flows used to estimate fair values and could result in a decline in fair value that would trigger future impairment charges of the Shave Care reporting unit's goodwill and indefinite-lived intangibles. As of March 31, 2020, the carrying values of the Shave Care goodwill and the Gillette indefinite-lived intangible asset were $12.4 billion and $14.1 billion, respectively. The duration and severity of the COVID-19 pandemic could result in additional future impairment charges for the Shave Care reporting unit goodwill and the Gillette indefinite-lived intangible asset. While we have concluded that a triggering event did not occur during the quarter ended March 31, 2020, a prolonged pandemic could impact the results of operations due to changes to assumptions utilized in the determination of the estimated fair values of Shave Care reporting unit and the Gillette indefinite-lived intangible asset that are significant enough to trigger an impairment. Net sales and earnings growth rates could be negatively impacted by reductions or changes in demand for our shave care products, which may be caused by, among other things: the temporary inability of consumers to purchase our products due to illness, quarantine or other travel restrictions, or financial hardship, or by shifts in demand away from one or more of our higher priced products to lower priced products. In addition, relative global and country/regional macroeconomic factors could result in additional and prolonged devaluation of other countries’ currencies relative to the dollar. Finally, the discount rate utilized in our valuation model could be impacted by changes in the underlying interest rates and risk premiums included in the determination of the cost of capital. The table below provides a sensitivity analysis for the Shave Care reporting unit and the Gillette indefinite lived intangible asset, utilizing reasonably possible changes in the assumptions for the shorter term and residual growth rates and the discount rate, to demonstrate the potential impacts to the estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate or a 25 basis-point decrease in our shorter-term and residual growth rates, either of which, in isolation, would result in an additional impairment of the Gillette indefinite-lived intangible asset. Approximate Percent Change in Estimated Fair Value +25 bps Discount Rate -25 bps Growth Rates Shave Care goodwill reporting unit (6) % (6) % Gillette indefinite-lived intangible asset (6) % (6) %

EARNINGS PER SHARE

EARNINGS PER SHARE	9 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Earnings Per Share Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated using the treasury stock method, on the basis of the weighted average number of common shares outstanding plus the dilutive effect of stock options and other stock-based awards and the assumed conversion of preferred stock. Net earnings per share were as follows: CONSOLIDATED AMOUNTS Three Months Ended March 31 Nine Months Ended March 31 2020 2019 2020 2019 Net earnings $ 2,957 $ 2,776 $ 10,317 $ 9,203 Less: Net earnings attributable to noncontrolling interests 40 31 90 65 Net earnings attributable to P&G (Diluted) 2,917 2,745 10,227 9,138 Preferred dividends (64) (64) (193) (195) Net earnings attributable to P&G available to common shareholders (Basic) $ 2,853 $ 2,681 $ 10,034 $ 8,943 SHARES IN MILLIONS Basic weighted average common shares outstanding 2,476.2 2,509.1 2,489.1 2,501.5 Add: Effect of dilutive securities Conversion of preferred shares (1) 85.5 89.6 86.4 90.8 Impact of stock options and other unvested equity awards (2) 51.6 39.0 54.8 32.0 Diluted weighted average common shares outstanding 2,613.3 2,637.7 2,630.3 2,624.3 NET EARNINGS PER SHARE (3) Basic $ 1.15 $ 1.07 $ 4.03 $ 3.58 Diluted $ 1.12 $ 1.04 $ 3.89 $ 3.48 (1) Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035. (2) Weighted average outstanding stock options of approximately 7 million and 4 million for the three months ended March 31, 2020 and 2019, and approximately 3 million and 25 million for the nine months ended March 31, 2020 and 2019 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares). (3) Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

SHARE-BASED COMPENSATION AND PO

SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS	9 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Compensation and Employee Benefit Plans [Text Block]	Share-Based Compensation and Postretirement Benefits The following table provides a summary of our share-based compensation expense and postretirement benefit costs: Three Months Ended March 31 Nine Months Ended March 31 2020 2019 2020 2019 Share-based compensation expense $ 123 $ 118 $ 325 $ 299 Net periodic benefit cost for pension benefits (1) 42 30 126 94 Net periodic benefit cost/(credit) for other retiree benefits (1) (52) (41) (156) (124) (1) The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for these interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2019.

RISK MANAGEMENT ACTIVITIES AND

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS	9 Months Ended
	Mar. 31, 2020
Risk Management Activities and Fair Value Measurements [Abstract]
Risk Management And Fair Value [Text Block]	Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the nine months ended March 31, 2020. The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were remeasured at fair value on a non-recurring basis for the nine months ended March 31, 2020. Other investments had a fair value of $50 and $169 as of March 31, 2020 and June 30, 2019, respectively, and are presented in Other noncurrent assets. During the nine months ended March 31, 2020, the Company sold all of its existing U.S. government securities and corporate bond securities. Such securities were presented in Available-for-sale investment securities at June 30, 2019, and had fair values of $3,648 and $2,400, respectively. The Company's investments measured at fair value are generally classified as Level 2 within the fair value hierarchy. Cash equivalents were $14,171 and $2,956 as of March 31, 2020 and June 30, 2019, respectively, and are classified as Level 1 within the fair value hierarchy. There are no other material investment balances classified as Level 1 or Level 3 within the fair value hierarchy or using net asset value as a practical expedient. Fair values are generally estimated based upon quoted market prices for similar instruments. The fair value of long-term debt was $28,602 and $25,378 as of March 31, 2020 and June 30, 2019, respectively. This includes the current portion of long-term debt instruments ($3,473 and $3,390 as of March 31, 2020 and June 30, 2019, respectively). Certain long-term debt (debt designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments. Disclosures about Financial Instruments The notional amounts and fair values of financial instruments used in hedging transactions as of March 31, 2020 and June 30, 2019 are as follows: Notional Amount Fair Value Asset Fair Value (Liability) March 31, 2020 June 30, 2019 March 31, 2020 June 30, 2019 March 31, 2020 June 30, 2019 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ 7,015 $ 7,721 $ 232 $ 177 $ — $ (1) DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS Foreign currency interest rate contracts $ 3,279 $ 3,157 $ 69 $ 35 $ (10) $ (24) TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS $ 10,294 $ 10,878 $ 301 $ 212 $ (10) $ (25) DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ 6,001 $ 6,431 $ 47 $ 27 $ (76) $ (20) TOTAL DERIVATIVES AT FAIR VALUE $ 16,295 $ 17,309 $ 348 $ 239 $ (86) $ (45) All derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. All derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities. The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $7,217 and $7,860 as of March 31, 2020 and June 30, 2019, respectively. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $16,765 and $17,154 as of March 31, 2020 and June 30, 2019, respectively. Changes in the fair value of net investment hedges are recognized in the Foreign currency translation component of Other comprehensive income (OCI). All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows: Amount of Gain/(Loss) Recognized in OCI on Derivatives Three Months Ended March 31 Nine Months Ended March 31 2020 2019 2020 2019 DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2) Foreign exchange contracts $ 83 $ 34 $ 114 $ 53 (1) For the derivatives in net investment hedging relationships, the amount of gain/(loss) excluded from effectiveness testing, which was recognized in earnings, was $17 and $17 for the three months ended March 31, 2020 and 2019, respectively. The amount of gain/(loss) excluded from effectiveness testing was $57 and $44 for the nine months ended March 31, 2020 and 2019, respectively. (2) In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income/(loss) (AOCI) for such instruments was $306 and $226 for the three months ended March 31, 2020 and 2019, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $487 and $467 for the nine months ended March 31, 2020 and 2019, respectively. Amount of Gain/(Loss) Recognized in Earnings Three Months Ended March 31 Nine Months Ended March 31 2020 2019 2020 2019 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ 109 $ 21 $ 56 $ 39 DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ (148) $ 75 $ (160) $ 68 The gain/(loss) on the derivatives in fair value hedging relationships is fully offset by the mark-to-market impact of the related exposure. These are both recognized in the Consolidated Statements of Earnings in Interest expense. The gain/(loss) on derivatives not designated as hedging instruments is substantially offset by the currency mark-to-market of the related exposure. These are both recognized in the Consolidated Statements of Earnings in Selling, general and administrative expense (SG&A).

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	9 Months Ended
	Mar. 31, 2020
Statement of Comprehensive Income [Abstract]
Comprehensive Income (Loss) Note [Text Block]	Accumulated Other Comprehensive Income/(Loss) The table below presents the changes in AOCI, including the reclassifications out of AOCI by component: Investment Securities Pension and Other Retiree Benefits Foreign Currency Translation Total AOCI Balance at June 30, 2019 $ 11 $ (4,198) $ (10,749) $ (14,936) OCI before reclassifications (1) (10) 104 (1,312) (1,218) Amounts reclassified from AOCI into the Consolidated Statements of Earnings (2) (2) 223 — 221 Net current period OCI (12) 327 (1,312) (997) Less: Other comprehensive income/(loss) attributable to non-controlling interests — — (17) (17) Balance at March 31, 2020 $ (1) $ (3,871) $ (12,044) $ (15,916) (1) Net of tax expense/(benefit) of $(2), $51 and $141 for gains/losses on investment securities, pension and other retiree benefit items and foreign currency translation, respectively. (2) Net of tax expense/(benefit) of $0, $66 and $0 for gains/losses on investment securities, pension and other retiree benefit items and foreign currency translation, respectively. The below provides additional details on amounts reclassified from AOCI into the Consolidated Statements of Earnings: • Investment securities: amounts reclassified from AOCI into Other non-operating income, net. • Pension and other retiree benefits: amounts reclassified from AOCI into Other non-operating income, net and included in the computation of net periodic postretirement costs.

RESTRUCTURING PROGRAM

RESTRUCTURING PROGRAM	9 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	Restructuring Program The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before-tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. In fiscal 2017 the Company announced specific elements of a multi-year productivity and cost savings plan to further reduce costs in the areas of supply chain, certain marketing activities and overhead expenses. This program is expected to result in incremental targeted enrollment reductions, along with further optimization of the supply chain and other manufacturing processes. Restructuring costs incurred consist primarily of costs to separate employees, asset-related costs to exit facilities and other costs. For the three and nine month period ended March 31, 2020, the Company incurred total restructuring charges of $222 and $420, respectively. Of these charges incurred, approximately $198 and $331 were recorded in Cost of products sold and approximately $21 and $80 were recorded in SG&A, respectively. The remainder of these charges were recorded in Other non-operating income, net. The following table presents restructuring activity for the nine months ended March 31, 2020: Reserve Balance Charges Previously Reported (Six Months Ended December 31, 2019) Charges for the Three Months Ended March 31, 2020 Nine Months Ended March 31, 2020 Reserve Balance June 30, 2019 Cash Spent Charges Against Assets March 31, 2020 Separations $ 280 $ 81 $ 41 $ (170) $ — $ 232 Asset-related costs — 73 148 — (221) — Other costs 188 44 33 (107) — 158 Total $ 468 $ 198 $ 222 $ (277) $ (221) $ 390 Separation Costs Employee separation charges for the three and nine month period ended March 31, 2020 relate to severance packages for approximately 350 and 720 employees, respectively. The packages were primarily voluntary and the amounts were calculated based on salary levels and past service periods. Severance costs related to voluntary separations are generally charged to earnings when the employee accepts the offer. Asset-Related Costs Asset-related costs consist of both asset write-downs and accelerated depreciation. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or disposal. These assets were written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. These assets relate primarily to manufacturing consolidations and technology standardizations. The asset-related charges will not have a significant impact on future depreciation charges. Other Costs Other restructuring-type charges are incurred as a direct result of the restructuring program. Such charges primarily include asset removal and termination of contracts related to supply chain optimization. Consistent with our historical policies for ongoing restructuring-type activities, the restructuring program charges are funded by and included within Corporate for both management and segment reporting. Accordingly, all of the charges under the program are included within the Corporate reportable segment. However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments: Three Months Ended March 31, 2020 Nine Months Ended March 31, 2020 Beauty $ 16 $ 29 Grooming 20 52 Health Care 65 89 Fabric & Home Care 6 17 Baby, Feminine & Family Care 63 92 Corporate (1) 52 141 Total Company $ 222 $ 420 (1) Corporate includes costs related to allocated overheads, including charges related to our Market Operations, Global Business Services and Corporate Functions activities.

LEASES

LEASES	9 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Lessee, Operating Leases [Text Block]	Leases The Company determines whether a contract contains a lease at the inception of a contract by determining if the contract conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. We lease certain real estate, machinery, equipment, vehicles and office equipment for varying periods. Many of these leases include an option to either renew or terminate the lease. For purposes of calculating lease liabilities, these options are included within the lease term when it has become reasonably certain that the Company will exercise such options. The incremental borrowing rate utilized to calculate our lease liabilities is based on the information available at commencement date, as most of the leases do not provide an implicit borrowing rate. The Company does not have any material financing lease or sublease activities. The Company incurred lease expense for operating leases of $82 and $255 for the three and nine months ended March 31, 2020, respectively. Total cash paid related to leases during the three and nine months ended March 31, 2020 was $60 and $205, respectively, including amounts expensed and amounts capitalized. Short-term leases, defined as leases with initial terms of 12 months or less, are not reflected on the Consolidated Balance Sheets. Lease expense for such short-term leases is not material. The most significant assets in our leasing portfolio relate to real estate and vehicles. For purposes of calculating lease liabilities for such leases, we have combined lease and non-lease components. The right-of-use assets obtained in exchange for new lease liabilities were $42 and $70 for the three and nine months ended March 31, 2020, respectively. Supplemental balance sheet and other information related to leases is as follows: March 31, 2020 Operating leases: Other noncurrent assets $ 855 Accrued and other liabilities 245 Other noncurrent liabilities 645 Total operating lease liabilities $ 890 Weighted average remaining lease term: Operating leases 6.4 years Weighted average discount rate: Operating leases 4.4 % At March 31, 2020, future payments of operating lease liabilities were as follows: Operating Leases March 31, 2020 1 year $ 245 2 years 193 3 years 159 4 years 134 5 years 93 Over 5 years 199 Total lease payments 1,023 Less: Interest (133) Present value of lease liabilities $ 890 As of June 30, 2019, minimum lease payments under non-cancelable operating leases by fiscal year were expected to be: Operating Leases June 30, 2019 2020 $ 263 2021 209 2022 165 2023 141 2024 121 After 2024 244 Total lease payments $ 1,143

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Commitments and Contingencies Litigation We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows. Income Tax Uncertainties The Company is present in approximately 70 countries and over 150 taxable jurisdictions and, at any point in time, has 40–50 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2008 and forward. We are generally not able to reliably estimate the ultimate settlement amounts until the close of the audit. Based on information currently available, we anticipate that over the next 12 month period, audit activity could be completed related to uncertain tax positions in multiple jurisdictions for which we have accrued existing liabilities of approximately $50, including interest and penalties. Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the year ended June 30, 2019.

ACQUISITION

ACQUISITION	9 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	Merck Acquisition On November 30, 2018, we completed our acquisition of the OTC healthcare business of Merck KGaA (Merck OTC) for $3.7 billion (based on exchange rates at the time of closing) in an all-cash transaction. This business primarily sells OTC consumer healthcare products, mainly in Europe, Latin America and Asia markets. The results of Merck OTC, which are not material to the Company, are reported in our consolidated financial statements beginning December 1, 2018. During the quarter ended December 31, 2019, we completed the allocation of the purchase price to the individual assets acquired and liabilities assumed. The allocation is based on the final determination of fair values of the assets and liabilities acquired. The following table presents the allocation of purchase price related to the Merck OTC business as of the date of the acquisition: Amounts in millions November 30, 2018 Current assets $ 421 Property, plant and equipment 119 Intangible assets 2,134 Goodwill 2,083 Other non-current assets 209 Total assets acquired $ 4,966 Current liabilities $ 232 Deferred income taxes 763 Non-current liabilities 94 Total liabilities acquired $ 1,089 Noncontrolling interest (1) $ 169 Net assets acquired $ 3,708 (1) Represents a 48% minority ownership interest in the Merck India company. The acquisition resulted in $2.1 billion in goodwill, of which approximately $180 million is expected to be deductible for tax purposes. All of this goodwill was allocated to the Health Care reportable segment. The fair value of Merck OTC’s identifiable intangible assets is $2.1 billion. The allocation of identifiable intangible assets and their average useful lives is as follows: Amounts in millions Estimated Fair Value Avg Remaining Intangible assets with determinable lives Brands $ 701 14 Patents and technology 162 10 Customer relationships 325 20 Total $ 1,188 15 Intangible assets with indefinite lives Brands 946 Total intangible assets $ 2,134

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Our operating segments are comprised of similar product categories. Operating segments that individually accounted for 5% or more of consolidated net sales are as follows: % of Net sales by operating segment (1) Three Months Ended March 31 Nine Months Ended March 31 2020 2019 2020 2019 Fabric Care 23% 22% 23% 23% Baby Care 11% 12% 11% 12% Home Care 11% 11% 10% 10% Skin and Personal Care 9% 10% 10% 10% Hair Care 9% 9% 9% 9% Family Care 9% 8% 9% 9% Oral Care 8% 8% 8% 8% Shave Care 7% 8% 7% 8% Feminine Care 7% 6% 6% 6% Personal Health Care 5% 5% 5% 4% Other 1% 1% 2% 1% Total 100% 100% 100% 100% (1) % of Net sales by operating segment excludes sales held in Corporate. Following is a summary of reportable segment results: Three Months Ended March 31 Nine Months Ended March 31 Net Sales Earnings/(Loss) Before Income Taxes Net Earnings Net Sales Earnings/(Loss) Before Income Taxes Net Earnings Beauty 2020 $ 3,033 $ 553 $ 436 $ 10,183 $ 2,717 $ 2,168 2019 3,061 675 551 9,707 2,586 2,082 Grooming 2020 1,380 305 254 4,559 1,225 1,018 2019 1,424 329 344 4,603 1,194 1,062 Health Care 2020 2,262 523 408 7,013 1,795 1,380 2019 2,115 462 358 6,180 1,571 1,210 Fabric & Home Care 2020 5,826 1,271 957 17,445 3,887 2,960 2019 5,382 1,114 847 16,427 3,392 2,584 Baby, Feminine & Family Care 2020 4,597 1,130 859 13,746 3,340 2,552 2019 4,357 861 653 13,305 2,693 2,052 Corporate 2020 116 (284) 43 306 (591) 239 2019 123 (163) 23 368 (302) 213 Total Company 2020 $ 17,214 $ 3,498 $ 2,957 $ 53,252 $ 12,373 $ 10,317 2019 16,462 3,278 2,776 50,590 11,134 9,203

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	9 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]	Goodwill is allocated by reportable segment as follows: Beauty Grooming Health Care Fabric & Home Care Baby, Feminine & Family Care Total Company Goodwill at June 30, 2019 $ 12,985 $ 12,881 $ 7,972 $ 1,855 $ 4,580 $ 40,273 Acquisitions and divestitures (1) — (46) — 5 (42) Translation and other (189) (143) (201) (23) (58) (614) Goodwill at March 31, 2020 $ 12,795 $ 12,738 $ 7,725 $ 1,832 $ 4,527 $ 39,617
Schedule of Intangible Assets and Goodwill [Table Text Block]	Identifiable intangible assets at March 31, 2020 were comprised of: Gross Carrying Amount Accumulated Amortization Intangible assets with determinable lives $ 8,458 $ (5,628) Intangible assets with indefinite lives 21,004 — Total identifiable intangible assets $ 29,462 $ (5,628)
Schedule of Potential Impacts to Estimated Fair Values [Table Text Block]	The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate or a 25 basis-point decrease in our shorter-term and residual growth rates, either of which, in isolation, would result in an additional impairment of the Gillette indefinite-lived intangible asset. Approximate Percent Change in Estimated Fair Value +25 bps Discount Rate -25 bps Growth Rates Shave Care goodwill reporting unit (6) % (6) % Gillette indefinite-lived intangible asset (6) % (6) %

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	9 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Net earnings per share were as follows: CONSOLIDATED AMOUNTS Three Months Ended March 31 Nine Months Ended March 31 2020 2019 2020 2019 Net earnings $ 2,957 $ 2,776 $ 10,317 $ 9,203 Less: Net earnings attributable to noncontrolling interests 40 31 90 65 Net earnings attributable to P&G (Diluted) 2,917 2,745 10,227 9,138 Preferred dividends (64) (64) (193) (195) Net earnings attributable to P&G available to common shareholders (Basic) $ 2,853 $ 2,681 $ 10,034 $ 8,943 SHARES IN MILLIONS Basic weighted average common shares outstanding 2,476.2 2,509.1 2,489.1 2,501.5 Add: Effect of dilutive securities Conversion of preferred shares (1) 85.5 89.6 86.4 90.8 Impact of stock options and other unvested equity awards (2) 51.6 39.0 54.8 32.0 Diluted weighted average common shares outstanding 2,613.3 2,637.7 2,630.3 2,624.3 NET EARNINGS PER SHARE (3) Basic $ 1.15 $ 1.07 $ 4.03 $ 3.58 Diluted $ 1.12 $ 1.04 $ 3.89 $ 3.48 (1) Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035. (2) Weighted average outstanding stock options of approximately 7 million and 4 million for the three months ended March 31, 2020 and 2019, and approximately 3 million and 25 million for the nine months ended March 31, 2020 and 2019 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares). (3) Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

SHARE-BASED COMPENSATION AND _2

SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Tables)	9 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Compensation and Employee Benefit Plans [Table Text Block]	The following table provides a summary of our share-based compensation expense and postretirement benefit costs: Three Months Ended March 31 Nine Months Ended March 31 2020 2019 2020 2019 Share-based compensation expense $ 123 $ 118 $ 325 $ 299 Net periodic benefit cost for pension benefits (1) 42 30 126 94 Net periodic benefit cost/(credit) for other retiree benefits (1) (52) (41) (156) (124) (1) The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for these interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2019.

RISK MANAGEMENT ACTIVITIES AN_2

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Mar. 31, 2020
Risk Management Activities and Fair Value Measurements [Abstract]
Schedule of Derivative Instruments [Table Text Block]	The notional amounts and fair values of financial instruments used in hedging transactions as of March 31, 2020 and June 30, 2019 are as follows: Notional Amount Fair Value Asset Fair Value (Liability) March 31, 2020 June 30, 2019 March 31, 2020 June 30, 2019 March 31, 2020 June 30, 2019 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ 7,015 $ 7,721 $ 232 $ 177 $ — $ (1) DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS Foreign currency interest rate contracts $ 3,279 $ 3,157 $ 69 $ 35 $ (10) $ (24) TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS $ 10,294 $ 10,878 $ 301 $ 212 $ (10) $ (25) DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ 6,001 $ 6,431 $ 47 $ 27 $ (76) $ (20) TOTAL DERIVATIVES AT FAIR VALUE $ 16,295 $ 17,309 $ 348 $ 239 $ (86) $ (45)
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]	Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows: Amount of Gain/(Loss) Recognized in OCI on Derivatives Three Months Ended March 31 Nine Months Ended March 31 2020 2019 2020 2019 DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2) Foreign exchange contracts $ 83 $ 34 $ 114 $ 53 (1) For the derivatives in net investment hedging relationships, the amount of gain/(loss) excluded from effectiveness testing, which was recognized in earnings, was $17 and $17 for the three months ended March 31, 2020 and 2019, respectively. The amount of gain/(loss) excluded from effectiveness testing was $57 and $44 for the nine months ended March 31, 2020 and 2019, respectively.
Derivative Instruments, Gain (Loss) [Table Text Block]	Amount of Gain/(Loss) Recognized in Earnings Three Months Ended March 31 Nine Months Ended March 31 2020 2019 2020 2019 DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS Interest rate contracts $ 109 $ 21 $ 56 $ 39 DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS Foreign currency contracts $ (148) $ 75 $ (160) $ 68

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)	9 Months Ended
	Mar. 31, 2020
Statement of Comprehensive Income [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The table below presents the changes in AOCI, including the reclassifications out of AOCI by component: Investment Securities Pension and Other Retiree Benefits Foreign Currency Translation Total AOCI Balance at June 30, 2019 $ 11 $ (4,198) $ (10,749) $ (14,936) OCI before reclassifications (1) (10) 104 (1,312) (1,218) Amounts reclassified from AOCI into the Consolidated Statements of Earnings (2) (2) 223 — 221 Net current period OCI (12) 327 (1,312) (997) Less: Other comprehensive income/(loss) attributable to non-controlling interests — — (17) (17) Balance at March 31, 2020 $ (1) $ (3,871) $ (12,044) $ (15,916) (1) Net of tax expense/(benefit) of $(2), $51 and $141 for gains/losses on investment securities, pension and other retiree benefit items and foreign currency translation, respectively. (2) Net of tax expense/(benefit) of $0, $66 and $0 for gains/losses on investment securities, pension and other retiree benefit items and foreign currency translation, respectively.

RESTRUCTURING PROGRAM (Tables)

RESTRUCTURING PROGRAM (Tables)	9 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	The following table presents restructuring activity for the nine months ended March 31, 2020: Reserve Balance Charges Previously Reported (Six Months Ended December 31, 2019) Charges for the Three Months Ended March 31, 2020 Nine Months Ended March 31, 2020 Reserve Balance June 30, 2019 Cash Spent Charges Against Assets March 31, 2020 Separations $ 280 $ 81 $ 41 $ (170) $ — $ 232 Asset-related costs — 73 148 — (221) — Other costs 188 44 33 (107) — 158 Total $ 468 $ 198 $ 222 $ (277) $ (221) $ 390
Restructuring and Related Costs [Table Text Block]	However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments: Three Months Ended March 31, 2020 Nine Months Ended March 31, 2020 Beauty $ 16 $ 29 Grooming 20 52 Health Care 65 89 Fabric & Home Care 6 17 Baby, Feminine & Family Care 63 92 Corporate (1) 52 141 Total Company $ 222 $ 420 (1) Corporate includes costs related to allocated overheads, including charges related to our Market Operations, Global Business Services and Corporate Functions activities.

LEASES - SUPPLEMENTAL BALANCE S

LEASES - SUPPLEMENTAL BALANCE SHEET (Tables)	9 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Assets and Liabilities, Lessee [Table Text Block]	Supplemental balance sheet and other information related to leases is as follows: March 31, 2020 Operating leases: Other noncurrent assets $ 855 Accrued and other liabilities 245 Other noncurrent liabilities 645 Total operating lease liabilities $ 890 Weighted average remaining lease term: Operating leases 6.4 years Weighted average discount rate: Operating leases 4.4 %

LEASES - FUTURE MATURITIES (Tab

LEASES - FUTURE MATURITIES (Tables)	9 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	At March 31, 2020, future payments of operating lease liabilities were as follows: Operating Leases March 31, 2020 1 year $ 245 2 years 193 3 years 159 4 years 134 5 years 93 Over 5 years 199 Total lease payments 1,023 Less: Interest (133) Present value of lease liabilities $ 890 As of June 30, 2019, minimum lease payments under non-cancelable operating leases by fiscal year were expected to be: Operating Leases June 30, 2019 2020 $ 263 2021 209 2022 165 2023 141 2024 121 After 2024 244 Total lease payments $ 1,143

ACQUISITION - ALLOCATION OF PUR

ACQUISITION - ALLOCATION OF PURCHASE PRICE (Tables)	9 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The allocation is based on the final determination of fair values of the assets and liabilities acquired. The following table presents the allocation of purchase price related to the Merck OTC business as of the date of the acquisition: Amounts in millions November 30, 2018 Current assets $ 421 Property, plant and equipment 119 Intangible assets 2,134 Goodwill 2,083 Other non-current assets 209 Total assets acquired $ 4,966 Current liabilities $ 232 Deferred income taxes 763 Non-current liabilities 94 Total liabilities acquired $ 1,089 Noncontrolling interest (1) $ 169 Net assets acquired $ 3,708 (1) Represents a 48% minority ownership interest in the Merck India company.

ACQUISITION - FAIR VALUE OF INT

ACQUISITION - FAIR VALUE OF INTANGIBLES (Tables)	9 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]	The allocation of identifiable intangible assets and their average useful lives is as follows: Amounts in millions Estimated Fair Value Avg Remaining Intangible assets with determinable lives Brands $ 701 14 Patents and technology 162 10 Customer relationships 325 20 Total $ 1,188 15 Intangible assets with indefinite lives Brands 946 Total intangible assets $ 2,134

NEW ACCOUNTING PRONOUNCEMENTS_2

NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES - EFFECT OF ADOPTION (Details)	Jul. 01, 2019
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	1.00%

SEGMENT INFORMATION - SALES (De

SEGMENT INFORMATION - SALES (Details)		3 Months Ended		9 Months Ended
		Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	100.00%	100.00%	100.00%	100.00%
Fabric Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	23.00%	22.00%	23.00%	23.00%
Baby Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	11.00%	12.00%	11.00%	12.00%
Home Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	11.00%	11.00%	10.00%	10.00%
Skin and Personal Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	9.00%	10.00%	10.00%	10.00%
Hair Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	9.00%	9.00%	9.00%	9.00%
Family Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	9.00%	8.00%	9.00%	9.00%
Oral Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	8.00%	8.00%	8.00%	8.00%
Shave Care
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	7.00%	8.00%	7.00%	8.00%
Feminine Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	7.00%	6.00%	6.00%	6.00%
Personal Health Care [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	5.00%	5.00%	5.00%	4.00%
All Other [Member]
Segment Reporting Information [Line Items]
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit	[1]	1.00%	1.00%	2.00%	1.00%
[1]	% of Net sales by operating segment excludes sales held in Corporate.

SEGMENT INFORMATION (Details)

SEGMENT INFORMATION (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Net Sales	$ 17,214	$ 16,462	$ 53,252	$ 50,590
Earnings/(Loss) from Continuing Operations Before Income Taxes	3,498	3,278	12,373	11,134
Net Earnings/(Loss) from Continuing Operations	2,957	2,776	10,317	9,203
Beauty
Segment Reporting Information [Line Items]
Net Sales	3,033	3,061	10,183	9,707
Earnings/(Loss) from Continuing Operations Before Income Taxes	553	675	2,717	2,586
Net Earnings/(Loss) from Continuing Operations	436	551	2,168	2,082
Grooming
Segment Reporting Information [Line Items]
Net Sales	1,380	1,424	4,559	4,603
Earnings/(Loss) from Continuing Operations Before Income Taxes	305	329	1,225	1,194
Net Earnings/(Loss) from Continuing Operations	254	344	1,018	1,062
Health Care
Segment Reporting Information [Line Items]
Net Sales	2,262	2,115	7,013	6,180
Earnings/(Loss) from Continuing Operations Before Income Taxes	523	462	1,795	1,571
Net Earnings/(Loss) from Continuing Operations	408	358	1,380	1,210
Fabric and Home Care
Segment Reporting Information [Line Items]
Net Sales	5,826	5,382	17,445	16,427
Earnings/(Loss) from Continuing Operations Before Income Taxes	1,271	1,114	3,887	3,392
Net Earnings/(Loss) from Continuing Operations	957	847	2,960	2,584
Baby, Feminine & Family Care
Segment Reporting Information [Line Items]
Net Sales	4,597	4,357	13,746	13,305
Earnings/(Loss) from Continuing Operations Before Income Taxes	1,130	861	3,340	2,693
Net Earnings/(Loss) from Continuing Operations	859	653	2,552	2,052
Corporate
Segment Reporting Information [Line Items]
Net Sales	116	123	306	368
Earnings/(Loss) from Continuing Operations Before Income Taxes	(284)	(163)	(591)	(302)
Net Earnings/(Loss) from Continuing Operations	$ 43	$ 23	$ 239	$ 213

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS - CHANGE IN THE NET CARRYING AMOUNT OF GOODWILL BY GLOBAL BUSINESS UNIT (Details) $ in Millions	9 Months Ended
	Mar. 31, 2020USD ($)
Goodwill [Roll Forward]
Goodwill at June 30, 2019	$ 40,273
Goodwill, Acquisitions and Divestitures	(42)
Goodwill, Translation and Other	(614)
Goodwill at March 31, 2020	39,617
Beauty
Goodwill [Roll Forward]
Goodwill at June 30, 2019	12,985
Goodwill, Acquisitions and Divestitures	(1)
Goodwill, Translation and Other	(189)
Goodwill at March 31, 2020	12,795
Grooming
Goodwill [Roll Forward]
Goodwill at June 30, 2019	12,881
Goodwill, Acquisitions and Divestitures	0
Goodwill, Translation and Other	(143)
Goodwill at March 31, 2020	12,738
Health Care
Goodwill [Roll Forward]
Goodwill at June 30, 2019	7,972
Goodwill, Acquisitions and Divestitures	(46)
Goodwill, Translation and Other	(201)
Goodwill at March 31, 2020	7,725
Fabric & Home Care
Goodwill [Roll Forward]
Goodwill at June 30, 2019	1,855
Goodwill, Acquisitions and Divestitures	0
Goodwill, Translation and Other	(23)
Goodwill at March 31, 2020	1,832
Baby, Feminine & Family Care
Goodwill [Roll Forward]
Goodwill at June 30, 2019	4,580
Goodwill, Acquisitions and Divestitures	5
Goodwill, Translation and Other	(58)
Goodwill at March 31, 2020	4,527
Shave Care
Goodwill [Roll Forward]
Goodwill at March 31, 2020	$ 12,400

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS - IDENTIFIABLE INTANGIBLE ASSETS (Details) $ in Millions	Mar. 31, 2020USD ($)
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 29,462
Accumulated Amortization	(5,628)
Intangible Assets with Indefinite Lives
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	21,004
Accumulated Amortization	0
Intangible Assets with Determinable Lives
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	8,458
Accumulated Amortization	$ (5,628)

GOODWILL AND OTHER INTANGIBLE_5

GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Other Significant Noncash Transactions [Line Items]
Amortization of Intangible Assets	$ 87	$ 98	$ 274	$ 252
Goodwill	39,617		39,617		$ 40,273
Shave Care
Other Significant Noncash Transactions [Line Items]
Goodwill	12,400		12,400
Intangible Assets with Indefinite Lives | Gillette
Other Significant Noncash Transactions [Line Items]
Intangible Assets, Net (Including Goodwill)	$ 14,100		$ 14,100

GOODWILL AND OTHER INTANGIBLE_6

GOODWILL AND OTHER INTANGIBLE ASSETS - FAIR VALUE SENSITIVITY (Details)	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2019
Shave Care
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount		20.00%	20.00%
Intangible Assets with Indefinite Lives | Gillette
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount		5.00%
25 bps Increase Discount Rate [Member] | Intangible Assets with Indefinite Lives | Gillette
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Percent Change in Estimated Fair Value	(6.00%)
25 bps Decrease Long-Term Growth [Member] | Intangible Assets with Indefinite Lives | Gillette
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Percent Change in Estimated Fair Value	(6.00%)
Goodwill | 25 bps Increase Discount Rate [Member] | Shave Care
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Percent Change in Estimated Fair Value	(6.00%)
Goodwill | 25 bps Decrease Long-Term Growth [Member] | Shave Care
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]
Percent Change in Estimated Fair Value	(6.00%)

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share Reconciliation [Abstract]
Net Earnings		$ 2,957	$ 2,776	$ 10,317	$ 9,203
Net Income (Loss) Attributable to Noncontrolling Interest		40	31	90	65
Net Earnings/(Loss) Attributable to P&G (Diluted)		2,917	2,745	10,227	9,138
Dividends, Preferred Stock		(64)	(64)	(193)	(195)
Net Earnings/(Loss) Attributable to P&G Available to Common Shareholders (Basic)		$ 2,853	$ 2,681	$ 10,034	$ 8,943
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic Weighted Average Common Shares Outstanding		2,476.2	2,509.1	2,489.1	2,501.5
Effect of Dilutive Securities
Conversion of Preferred Shares	[1]	85.5	89.6	86.4	90.8
Exercise of Stock Options and Other Unvested Equity Awards	[2]	51.6	39	54.8	32
Diluted Weighted Average Common Shares Outstanding		2,613.3	2,637.7	2,630.3	2,624.3
Basic Net Earnings/(Loss) Per Common Share	[3],[4]	$ 1.15	$ 1.07	$ 4.03	$ 3.58
Diluted Net Earnings/(Loss) Per Common Share	[3],[4]	$ 1.12	$ 1.04	$ 3.89	$ 3.48
[1]	Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035.
[2]	Weighted average outstanding stock options of approximately 7 million and 4 million for the three months ended March 31, 2020 and 2019, and approximately 3 million and 25 million for the nine months ended March 31, 2020 and 2019 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).
[3]	Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[4]	Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

EARNINGS PER SHARE - ANTIDILUTI

EARNINGS PER SHARE - ANTIDILUTIVE SECURITIES (Details) - shares shares in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	[1]	7	4	3	25
[1]	Weighted average outstanding stock options of approximately 7 million and 4 million for the three months ended March 31, 2020 and 2019, and approximately 3 million and 25 million for the nine months ended March 31, 2020 and 2019 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).

SHARE-BASED COMPENSATION AND _3

SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]
Share-based Payment Arrangement, Expense		$ 123	$ 118	$ 325	$ 299
Pension Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	[1]	42	30	126	94
Other Postretirement Benefit Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	[1]	$ (52)	$ (41)	$ (156)	$ (124)
[1]	The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for these interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2019.

RISK MANAGEMENT ACTIVITIES AN_3

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - SCHEDULE OF DERIVATIVE INSTRUMENTS (Details) - USD ($) $ in Millions	Mar. 31, 2020	Jun. 30, 2019
Derivative [Line Items]
Derivative, Notional Amount	$ 16,295	$ 17,309
Derivative Asset	348	239
Derivative Liability	(86)	(45)
Derivatives in Fair Value Hedging Relationships | Interest Rate Contracts
Derivative [Line Items]
Derivative, Notional Amount	7,015	7,721
Derivative Asset	232	177
Derivative Liability	0	(1)
Derivatives in Net Investment Hedging Relationships | Foreign Exchange Contract
Derivative [Line Items]
Derivative, Notional Amount	3,279	3,157
Derivative Asset	69	35
Derivative Liability	(10)	(24)
Designated as Hedging Instrument
Derivative [Line Items]
Derivative, Notional Amount	10,294	10,878
Derivative Asset	301	212
Derivative Liability	(10)	(25)
Not Designated as Hedging Instrument | Foreign Exchange Contract
Derivative [Line Items]
Derivative, Notional Amount	6,001	6,431
Derivative Asset	47	27
Derivative Liability	$ (76)	$ (20)

RISK MANAGEMENT ACTIVITIES AN_4

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE INSTRUMENTS, EFFECT ON OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Derivatives in Net Investment Hedging Relationships | Foreign Exchange Contract
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Derivative Instruments, Net, Pretax	[1],[2]	$ 83	$ 34	$ 114	$ 53
[1]	For the derivatives in net investment hedging relationships, the amount of gain/(loss) excluded from effectiveness testing, which was recognized in earnings, was $17 and $17 for the three months ended March 31, 2020 and 2019, respectively. The amount of gain/(loss) excluded from effectiveness testing was $57 and $44 for the nine months ended March 31, 2020 and 2019, respectively.
[2]	In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income/(loss) (AOCI) for such instruments was $306 and $226 for the three months ended March 31, 2020 and 2019, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $487 and $467 for the nine months ended March 31, 2020 and 2019, respectively.

RISK MANAGEMENT ACTIVITIES AN_5

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE INSTRUMENTS, EFFECT ON OTHER COMPREHENSIVE INCOME (LOSS) - ADDITIONAL INFORMATION (Details) - Derivatives in Net Investment Hedging Relationships - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	$ 17	$ 17	$ 57	$ 44
Accumulated Other Comprehensive Income, Gain (Loss)	$ 306	$ 226	$ 487	$ 467

RISK MANAGEMENT ACTIVITIES AN_6

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE INSTRUMENTS GAIN (LOSS) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Not Designated as Hedging Instrument | Foreign Currency Contract
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Earnings	$ (148)	$ 75	$ (160)	$ 68
Derivatives in Fair Value Hedging Relationships | Interest Rate Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Earnings	$ 109	$ 21	$ 56	$ 39

RISK MANAGEMENT ACTIVITIES AN_7

RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	Mar. 31, 2020	Jun. 30, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents, at Carrying Value	$ 14,171	$ 2,956
Derivatives in Fair Value Hedging Relationships | Underlying, Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Underlying Debt Obligation, Carrying Amt	7,217	7,860
Derivatives in Net Investment Hedging Relationships | Underlying, Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Underlying Debt Obligation, Carrying Amt	16,765	17,154
US Government Agencies Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		3,648
Corporate Bond Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		2,400
Long-term Debt [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term Debt, Fair Value	28,602	25,378
Long Term Debt, Current Maturities Measured at Fair Value	3,473	3,390
Other Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	$ 50	$ 169

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - CHANGES IN AOCI AND RECLASSIFICATION OUT OF AOCI (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Accumulated Other Comprehensive Income/(Loss)		$ (15,916)		$ (15,916)		$ (14,936)
OCI before Reclassifications	[1]			(1,218)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	[2]			221
Other Comprehensive Income (Loss), Net of Tax		(985)	$ 191	(997)	$ 107
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest				(17)
Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member]
Other Comprehensive Income (Loss) before Reclassifications, Tax	[1]			141
Reclassification from AOCI, Current Period, Tax	[2]			0
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]
Other Comprehensive Income (Loss) before Reclassifications, Tax	[1]			(2)
Accumulated Other Comprehensive Income/(Loss)		(1)		(1)		11
OCI before Reclassifications	[1]			(10)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	[2]			(2)
Other Comprehensive Income (Loss), Net of Tax				(12)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest				0
Reclassification from AOCI, Current Period, Tax	[2]			0
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest
Other Comprehensive Income (Loss) before Reclassifications, Tax	[1]			51
Accumulated Other Comprehensive Income/(Loss)		(3,871)		(3,871)		(4,198)
OCI before Reclassifications	[1]			104
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	[2]			223
Other Comprehensive Income (Loss), Net of Tax				327
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest				0
Reclassification from AOCI, Current Period, Tax	[2]			66
Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income/(Loss)		$ (12,044)		(12,044)		$ (10,749)
OCI before Reclassifications	[1]			(1,312)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	[2]			0
Other Comprehensive Income (Loss), Net of Tax				(1,312)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest				$ (17)
[1]	Net of tax expense/(benefit) of $(2), $51 and $141 for gains/losses on investment securities, pension and other retiree benefit items and foreign currency translation, respectively.
[2]	Net of tax expense/(benefit) of $0, $66 and $0 for gains/losses on investment securities, pension and other retiree benefit items and foreign currency translation, respectively.

RESTRUCTURING PROGRAM - ADDITIO

RESTRUCTURING PROGRAM - ADDITIONAL INFORMATION (Details) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2020USD ($)employee	Dec. 31, 2019USD ($)	Mar. 31, 2020USD ($)employee
Restructuring Charges	$ 222	$ 198	$ 420
Minimum
Restructuring and Related Cost, Amounts Historically Incurred			250
Maximum
Restructuring and Related Cost, Amounts Historically Incurred			500
Cost of Goods and Service, Segment Benchmark [Member]
Restructuring Charges	198		331
Selling, General and Administrative Expenses [Member]
Restructuring Charges	21		$ 80
Separations
Restructuring Charges	$ 41	$ 81
Restructuring and Related Cost, Number of Severance Packages Executed | employee	350		720

RESTRUCTURING PROGRAM - RESTRUC

RESTRUCTURING PROGRAM - RESTRUCTURING RESERVE BY TYPE OF COSTS (Details) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2020USD ($)employee	Dec. 31, 2019USD ($)	Mar. 31, 2020USD ($)employee	Jun. 30, 2019USD ($)
Restructuring Reserve [Roll Forward]
Reserve Balance	$ 390		$ 390	$ 468
Restructuring Charges	222	$ 198	420
Cash Spent			(277)
Charges Against Assets			(221)
Separations
Restructuring Reserve [Roll Forward]
Reserve Balance	232		232	280
Restructuring Charges	$ 41	81
Cash Spent			(170)
Charges Against Assets			$ 0
Restructuring and Related Cost, Number of Severance Packages Executed | employee	350		720
Asset-related Costs
Restructuring Reserve [Roll Forward]
Reserve Balance	$ 0		$ 0	0
Restructuring Charges	148	73
Cash Spent			0
Charges Against Assets			(221)
Other Costs
Restructuring Reserve [Roll Forward]
Reserve Balance	158		158	$ 188
Restructuring Charges	$ 33	$ 44
Cash Spent			(107)
Charges Against Assets			$ 0

RESTRUCTURING PROGRAM - RESTR_2

RESTRUCTURING PROGRAM - RESTRUCTURING COSTS PER SEGMENT (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		$ 222	$ 198	$ 420
Beauty
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		16		29
Grooming
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		20		52
Health Care
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		65		89
Fabric & Home Care
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		6		17
Baby, Feminine & Family Care
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		63		92
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	[1]	$ 52		$ 141
[1]	Corporate includes costs related to allocated overheads, including charges related to our Market Operations, Global Business Services and Corporate Functions activities.

LEASES - SUPPLEMENTAL BALANCE_2

LEASES - SUPPLEMENTAL BALANCE SHEET (Details) $ in Millions	Mar. 31, 2020USD ($)Rate
Operating Leased Assets [Line Items]
Operating Lease, Right-of-Use Asset	$ 855
Operating Lease, Liability, Current	245
Operating Lease, Liability, Noncurrent	645
Operating Lease, Liability	$ 890
Operating Lease, Weighted Average Remaining Lease Term	6 years 4 months 24 days
Operating Lease, Weighted Average Discount Rate, Percent | Rate	4.40%

LEASES - FUTURE MATURITIES (Det

LEASES - FUTURE MATURITIES (Details) - USD ($) $ in Millions	Mar. 31, 2020	Jun. 30, 2019
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months	$ 245
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two	193
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three	159
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four	134
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five	93
Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five	199
Lessee, Operating Lease, Liability, Payments, Due	1,023
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(133)
Operating Lease, Liability	$ 890
Operating Leases, Future Minimum Payments Due, Next Twelve Months		$ 263
Operating Leases, Future Minimum Payments, Due in Two Years		209
Operating Leases, Future Minimum Payments, Due in Three Years		165
Operating Leases, Future Minimum Payments, Due in Four Years		141
Operating Leases, Future Minimum Payments, Due in Five Years		121
Operating Leases, Future Minimum Payments, Due Thereafter		244
Operating Leases, Future Minimum Payments Due		$ 1,143

LEASES ADDITIONAL INFORMATION (

LEASES ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2020
Operating Lease, Cost	$ 82	$ 255
Operating Lease, Payments	60	205
Operating Lease, Right-of-Use Asset	$ 42	$ 70

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - ADDITIONAL INFORMATION (Details) $ in Millions	9 Months Ended
	Mar. 31, 2020USD ($)taxable_jurisdictionauditcountries
Loss Contingencies [Line Items]
Number of Countries With On The Ground Operations | countries	70
Number of Taxable Jurisdictions | taxable_jurisdiction	150
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | $	$ 50
Minimum
Loss Contingencies [Line Items]
Number of Audits Typically Underway	40
Maximum
Loss Contingencies [Line Items]
Number of Audits Typically Underway	50

ACQUISITION - ALLOCATION OF P_2

ACQUISITION - ALLOCATION OF PURCHASE PRICE (Details) - USD ($) $ in Millions		Mar. 31, 2020	Jun. 30, 2019	Nov. 30, 2018
Business Acquisition [Line Items]
Goodwill		$ 39,617	$ 40,273
PHC-MERCK ACQUISITION [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets				$ 421
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment				119
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill				2,134
Goodwill				2,083
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets				209
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets				4,966
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities				232
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities				763
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities				94
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities				1,089
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value	[1]			169
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net				$ 3,708
Minority Interest Ownership Percentage				48.00%
[1]	Represents a 48% minority ownership interest in the Merck India company.

ACQUISITION ACQUISITION - FAIR

ACQUISITION ACQUISITION - FAIR VALUE OF INTANGIBLES (Details) - PHC-MERCK ACQUISITION [Member] $ in Millions	1 Months Ended
	Nov. 30, 2018USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 1,188
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	$ 2,134
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	15 years
Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 701
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	14 years
Patents and Developed Technology [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 162
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
Customer Relationships [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 325
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	20 years
Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets	$ 946

ACQUISITION - ADDITIONAL INFORM

ACQUISITION - ADDITIONAL INFORMATION (Details) - USD ($) $ in Millions	1 Months Ended	9 Months Ended
	Nov. 30, 2018	Mar. 31, 2020	Jun. 30, 2019
Business Acquisition [Line Items]
Goodwill		$ 39,617	$ 40,273
PHC-MERCK ACQUISITION [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	15 years
Payments to Acquire Businesses, Gross	$ 3,700
Goodwill	2,083
Business Acquisition, Goodwill, Expected Tax Deductible Amount	180
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	$ 2,134
Trade Names [Member] | PHC-MERCK ACQUISITION [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	14 years
Trade Names [Member] | Minimum | PHC-MERCK ACQUISITION [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		10 years
Trade Names [Member] | Maximum | PHC-MERCK ACQUISITION [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		20 years
Patents and Developed Technology [Member] | PHC-MERCK ACQUISITION [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
Customer Relationships [Member] | PHC-MERCK ACQUISITION [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	20 years